Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 56, Issue 9

Issues

Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer

Jérôme Solassol
  • Corresponding author
  • Department of Pathology, CHU Montpellier, University of Montpellier, Montpellier, France
  • Department of Biopathology, Institut du Cancer de Montpellier (ICM), University of Montpellier, Montpellier, France
  • Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, University of Montpellier, Montpellier, France
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Xavier Quantin
  • Department of Thoracic Oncology, CHU Montpellier, University of Montpellier, Montpellier, France
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Marion Larrieux / Romain Senal
  • Department of Biopathology, Institut du Cancer de Montpellier (ICM), University of Montpellier, Montpellier, France
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Patricia Audran
  • Department of Biopathology, Institut du Cancer de Montpellier (ICM), University of Montpellier, Montpellier, France
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ David Grand
  • Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, CHU de Toulouse, Toulouse, France
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Alain Mangé
  • Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, University of Montpellier, Montpellier, France
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Eleftherios P. Diamandis
  • Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
  • Department of Clinical Biochemistry, University Health Network, Toronto, Canada
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Julie A. Vendrell
Published Online: 2018-04-07 | DOI: https://doi.org/10.1515/cclm-2017-0967

References

  • 1.

    Vendrell JA, Mau-Them FT, Beganton B, Godreuil S, Coopman P, Solassol J. Circulating cell free tumor DNA detection as a routine tool for Lung Cancer Patient Management. Int J Mol Sci 2017;18:264.CrossrefWeb of ScienceGoogle Scholar

  • 2.

    Chmielecki J, Foo J, Oxnard GR, Hutchinson K, Ohashi K, Somwar R, et al. Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Sci Transl Med 2011;3:90ra59.Web of SciencePubMedGoogle Scholar

  • 3.

    Denis MG, Knol AC, Theoleyre S, Vallee A, Dreno B. Efficient detection of BRAF mutation in plasma of patients after long-term storage of blood in cell-free DNA blood collection tubes. Clin Chem 2015;61:886–8.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 4.

    Henao Diaz E, Yachnin J, Gronberg H, Lindberg J. The in vitro stability of circulating tumour DNA. PLoS One 2016;11: e0168153.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 5.

    Sherwood JL, Corcoran C, Brown H, Sharpe AD, Musilova M, Kohlmann A. Optimised pre-analytical methods improve KRAS mutation detection in circulating tumour DNA (ctDNA) from patients with non-small cell lung cancer (NSCLC). PLoS One 2016;11:e0150197.Web of ScienceCrossrefPubMedGoogle Scholar

  • 6.

    Sorber L, Zwaenepoel K, Deschoolmeester V, Roeyen G, Lardon F, Rolfo C, et al. A comparison of cell-free DNA isolation kits: isolation and quantification of cell-free DNA in plasma. J Mol Diagn 2017;19:162–8.CrossrefWeb of SciencePubMedGoogle Scholar

  • 7.

    Perez-Barrios C, Nieto-Alcolado I, Torrente M, Jimenez-Sanchez C, Calvo V, Gutierrez-Sanz L, et al. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing. Transl Lung Cancer Res 2016;5:665–72.CrossrefPubMedWeb of ScienceGoogle Scholar

About the article

Received: 2017-10-20

Accepted: 2018-02-19

Published Online: 2018-04-07

Published in Print: 2018-08-28


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 56, Issue 9, Pages e243–e246, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2017-0967.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Comments (0)

Please log in or register to comment.
Log in